ibr 70 mg (Imbruvica 70 mg)
Generic Name: ibrutinib
Pill with imprint ibr 70 mg is Yellow, Capsule-shape and has been identified as Imbruvica 70 mg. It is supplied by Pharmacyclics, Inc..
Imbruvica is used in the treatment of chronic lymphocytic leukemia; waldenström macroglobulinemia; non-hodgkin's lymphoma; mantle cell lymphoma; lymphoma and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 70 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ibr 70 mg
Imbruvica
- Generic Name
- ibrutinib
- Imprint
- ibr 70 mg
- Strength
- 70 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Btk inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pharmacyclics, Inc.
- National Drug Code (NDC)
- 57962-0070
More about Imbruvica (ibrutinib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 37 Reviews
- Generic Availability
- Drug class: BTK inhibitors
- FDA Approval History
Consumer resources
- Patient Information
- Imbruvica (Advanced Reading)
- Imbruvica (Ibrutinib Capsules)
- Imbruvica (Ibrutinib Tablets)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.